Inventor · disambiguated record
Thomas Langer
Also filed as: LANGER THOMAS
7 granted patents·19 pending applications·18 citations·filing 2008–2024
79Inventor score
Top patents by PatentIndex Score
26 records- 0189US10583174B2FGF21 compound / GLP-1R agonist combinations with optimized activity ratioSANOFI SA·Filed 2017·Granted Mar 10, 2020·6 cites·22 claims
- 0283US11230582B2FGF21 variantsSANOFI SA·Filed 2016·Granted Jan 25, 2022·2 cites·6 claims
- 0383US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 0479US2024366727A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2024·Application pending·0 cites
- 0578US11820809B2Multispecific antibodies facilitating selective light chain pairingSANOFI SA·Filed 2017·Granted Nov 21, 2023·2 cites·14 claims
- 0677US2025171512A1Fgf21 variantsSANOFI SA·Filed 2024·Application pending·0 cites
- 0771US2022401523A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2022·Application pending·0 cites
- 0871US2025115669A1FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic PeptidesSANOFI SA·Filed 2024·Application pending·0 cites
- 0966US2023391888A1Pseudofab-based multispecific binding proteinsSANOFI SA·Filed 2023·Application pending·0 cites
- 1066US2022227825A1Fgf21 variantsSANOFI SA·Filed 2021·Application pending·0 cites
- 1161US12054551B2FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptidesSANOFI SA·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 1261US11739160B2PseudoFab-based multispecific binding proteinsSANOFI SA·Filed 2019·Granted Aug 29, 2023·0 cites·36 claims
- 1360US2020261542A1Fgf21 compound / glp-1r agonist combinations with optimized activity ratioSANOFI SA·Filed 2020·Application pending·0 cites
- 1457US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 1556US2011177611A1Ligand binding domains of nuclear receptors in controllable form and methods involving the sameSANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 1654US2024043522A1Effectorless fc moleculesSANOFI SA·Filed 2021·Application pending·0 cites
- 1753US2019085043A1Fusion proteins for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 1853US2023103563A1Split ch2 domainsSANOFI SA·Filed 2021·Application pending·0 cites
- 1952US2023279151A1Protease-processed moleculesSANOFI SA·Filed 2021·Application pending·0 cites
- 2051US2014073563A1Fusion proteins for treating a metabolic syndromeBOSCHEINEN OLIVER·Filed 2013·Application pending·0 cites
- 2149US2023250147A1Glp-1r agonistic peptides with reduced activitySANOFI SA·Filed 2020·Application pending·0 cites
- 2249US2023265152A1Glp-1r agonist / fgf21 fusion proteinsSANOFI SA·Filed 2020·Application pending·0 cites
- 2348US2012282710A1Ligand binding domains of nuclear receptors in controllable form and methods involving the sameSCHWAHN UWE·Filed 2012·Application pending·0 cites
- 2446US2016194371A1Fusion proteins comprising FGF-21 and GLP-1R agonistSANOFI SA·Filed 2015·Application pending·0 cites
- 2539US2010209436A1Method for treating diseases related to mitochondrial dysfunctionREICHERT ANDREAS·Filed 2008·Application pending·0 cites
- 2630US2013189714A1Method for the detection and/or quantification of the interaction of platelets with interaction partnersDE HOOP MELTSJE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Langer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →